Copyright Reports & Markets. All rights reserved.

Global Pharmaceutical Asset Performance Management (APM)

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Pharmaceutical Asset Performance Management (APM) Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Pharmaceutical Asset Performance Management (APM) Market Size 2014-2024
        • 2.1.2 Pharmaceutical Asset Performance Management (APM) Market Size CAGR by Region
      • 2.2 Pharmaceutical Asset Performance Management (APM) Segment by Type
        • 2.2.1 Asset Integrity Management
        • 2.2.2 Asset Reliability Management
        • 2.2.3 Other
      • 2.3 Pharmaceutical Asset Performance Management (APM) Market Size by Type
        • 2.3.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type (2014-2019)
      • 2.4 Pharmaceutical Asset Performance Management (APM) Segment by Application
        • 2.4.1 Large Enterprises
        • 2.4.2 SMEs
      • 2.5 Pharmaceutical Asset Performance Management (APM) Market Size by Application
        • 2.5.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Application (2014-2019)

      3 Global Pharmaceutical Asset Performance Management (APM) by Players

      • 3.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Market Share by Players
        • 3.1.1 Global Pharmaceutical Asset Performance Management (APM) Market Size by Players (2017-2019)
        • 3.1.2 Global Pharmaceutical Asset Performance Management (APM) Market Size Market Share by Players (2017-2019)
      • 3.2 Global Pharmaceutical Asset Performance Management (APM) Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Pharmaceutical Asset Performance Management (APM) by Regions

      • 4.1 Pharmaceutical Asset Performance Management (APM) Market Size by Regions
      • 4.2 Americas Pharmaceutical Asset Performance Management (APM) Market Size Growth
      • 4.3 APAC Pharmaceutical Asset Performance Management (APM) Market Size Growth
      • 4.4 Europe Pharmaceutical Asset Performance Management (APM) Market Size Growth
      • 4.5 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size Growth

      5 Americas

      • 5.1 Americas Pharmaceutical Asset Performance Management (APM) Market Size by Countries
      • 5.2 Americas Pharmaceutical Asset Performance Management (APM) Market Size by Type
      • 5.3 Americas Pharmaceutical Asset Performance Management (APM) Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Pharmaceutical Asset Performance Management (APM) Market Size by Countries
      • 6.2 APAC Pharmaceutical Asset Performance Management (APM) Market Size by Type
      • 6.3 APAC Pharmaceutical Asset Performance Management (APM) Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Pharmaceutical Asset Performance Management (APM) by Countries
      • 7.2 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type
      • 7.3 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Pharmaceutical Asset Performance Management (APM) by Countries
      • 8.2 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size by Type
      • 8.3 Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Pharmaceutical Asset Performance Management (APM) Market Forecast

      • 10.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Forecast (2019-2024)
      • 10.2 Global Pharmaceutical Asset Performance Management (APM) Forecast by Regions
        • 10.2.1 Global Pharmaceutical Asset Performance Management (APM) Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Pharmaceutical Asset Performance Management (APM) Forecast by Type
      • 10.8 Global Pharmaceutical Asset Performance Management (APM) Forecast by Application

      11 Key Players Analysis

      • 11.1 GE (US)
        • 11.1.1 Company Details
        • 11.1.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.1.3 GE (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 GE (US) News
      • 11.2 Rockwell Software (US)
        • 11.2.1 Company Details
        • 11.2.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.2.3 Rockwell Software (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Rockwell Software (US) News
      • 11.3 AVEVA Group plc (UK)
        • 11.3.1 Company Details
        • 11.3.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.3.3 AVEVA Group plc (UK) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 AVEVA Group plc (UK) News
      • 11.4 Bentley Systems (US)
        • 11.4.1 Company Details
        • 11.4.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.4.3 Bentley Systems (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Bentley Systems (US) News
      • 11.5 AspenTech (US)
        • 11.5.1 Company Details
        • 11.5.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.5.3 AspenTech (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 AspenTech (US) News
      • 11.6 Nexus Global (US)
        • 11.6.1 Company Details
        • 11.6.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.6.3 Nexus Global (US) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Nexus Global (US) News
      • 11.7 SAP (Germany)
        • 11.7.1 Company Details
        • 11.7.2 Pharmaceutical Asset Performance Management (APM) Product Offered
        • 11.7.3 SAP (Germany) Pharmaceutical Asset Performance Management (APM) Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 SAP (Germany) News

      ...

        12 Research Findings and Conclusion

        Asset performance management (APM) is a proven approach to reduce unplanned downtime, decrease maintenance costs, and reduce EH&S risks.
        Pharmaceutical Asset Performance Management (APM) are mainly classified into the following types: APM Integrity, APM Reliability etc. APM Integrity, is the most widely used type which takes up about 46.1% of the total sales in 2018.
        United States is the largest region of Pharmaceutical Asset Performance Management (APM) in the world in the past few years and it will keep increasing in the next few years. United States market took up about 50% the global market in 2018, while Europe and China were about 27%, 7.4%.
        APM can extend Enterprise Asset Management (EAM) systems using powerful AI data and analytics. Although sales of Pharmaceutical Asset Performance Management (APM) bring a lot of opportunities, the study group recommends the new entrants who just have money but without technical advantage and downstream support, do not enter the Pharmaceutical Asset Performance Management (APM) field hastily.

        According to this study, over the next five years the Pharmaceutical Asset Performance Management (APM) market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 118.5 million by 2024, from US$ 90 million in 2019. In particular, this report presents the global revenue market share of key companies in Pharmaceutical Asset Performance Management (APM) business, shared in Chapter 3.

        This report presents a comprehensive overview, market shares and growth opportunities of Pharmaceutical Asset Performance Management (APM) market by product type, application, key companies and key regions.

        This study considers the Pharmaceutical Asset Performance Management (APM) value generated from the sales of the following segments:

        Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
        Asset Integrity Management
        Asset Reliability Management
        Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
        Large Enterprises
        SMEs

        This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
        Americas
        United States
        Canada
        Mexico
        Brazil
        APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

        The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
        GE (US)
        Rockwell Software (US)
        AVEVA Group plc (UK)
        Bentley Systems (US)
        AspenTech (US)
        Nexus Global (US)
        SAP (Germany)
        ...

        In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

        Research objectives
        To study and analyze the global Pharmaceutical Asset Performance Management (APM) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
        To understand the structure of Pharmaceutical Asset Performance Management (APM) market by identifying its various subsegments.
        Focuses on the key global Pharmaceutical Asset Performance Management (APM) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
        To analyze the Pharmaceutical Asset Performance Management (APM) with respect to individual growth trends, future prospects, and their contribution to the total market.
        To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
        To project the size of Pharmaceutical Asset Performance Management (APM) submarkets, with respect to key regions (along with their respective key countries).
        To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        Buy now